Multi-channel Marketing for Pharma: 9 Tips for Success
The Marketing Plan-Critical Success Factors
The secrets of a successful launch in pharmaceuticals
The top 10 drugmakers of 2024
What Are the Ethics of Neuromarketing?
Finding the Perfect Pace for Product Launches
New Apple Apps: Overdiagnosis, Useful Addition, or Both?
How to Make Your Drug Launch a Success
6 campaigns that break the status quo in healthcare marketing
The secret of successful drug launches
he autonomous car dropped Lori at her home and then left for its scheduled service at the dealership. It would be back in time to take her to the airport … Continue Reading Marketing in the Age of Alexa
Το 2ο Συνέδριο Υγείας της Ναυτεμπορικής Πέμπτη 20 Σεμπτεμβρίου 2018 , θα επιχειρήσει να διερευνήσει, να αναλύσει και να παρουσιάσει μέσα από τις τοποθετήσεις και τις συζητήσεις των πρωταγωνιστών του χώρου κατά … Continue Reading Το 2ο Συνέδριο Υγείας της Ναυτεμπορικής
In July, Pfizer’s anti-smoking medication Chantix got something of a facelift. Noted actor Ray Liotta of “Goodfellas” fame became the face of the medication. In the commercial, which is airing on most … Continue Reading Pharma Companies Create Memorable Ad Campaigns for Branded Products
In a quickly crowding ankylosing spondylitis market, Cimzia maker UCB is working hard stand out with its beyond-the-pill offerings. Back in January, it partnered on a spondyloarthritis social network, and … Continue Reading Cimzia maker UCB signs MyHealthTeams to pump up spondyloarthritis social network
Business leaders today must deal with the fastest-changing marketplace in history. Change in organizations is a fact of life for them. Effective leadership thus requires that they stay up to … Continue Reading 3 Trends in Organization Design Presenting Opportunities for Leaders
It’s that time of year again—the time when lead PBM Express Scripts ignites pharma’s ire with a brand-new list (PDF) of formulary exclusions. This time, Express Scripts barred 48 drugs from its … Continue Reading Express Scripts bars 48 drugs for 2019, hitting AbbVie, Gilead, Boehringer and more